emnify and Skylo to Unveil the First Converged Cellular and Satellite Connectivity at Mobile World Congress
21.9.2023 10:00:00 EEST | Business Wire | Press release
Today, emnify the leader in cloud-native IoT connectivity solutions, and Skylo, a global software-defined non-terrestrial network (NTN) operator focusing on connecting everything, everywhere, announce an industry-first convergence of satellite and cellular IoT connectivity from a single emnify SIM. Partnering with leading module manufacturer, Murata, the companies are expanding the next generation of IoT connectivity to space. The combination of emnify’s cloud-native, mobile core technology and direct IoT cellular access with providers around the globe, with Skylo’s NTN satellite access, provides seamless, intelligent, friction-free, network IoT connectivity.
The emnify IoT SuperNetwork, the industry’s first cloud-native IoT connectivity service with direct access to over 540 cellular networks in over 180 countries, provides access to Skylo’s satellite NTN services, marking the first and only single SIM access to global IoT connectivity on terrestrial and non-terrestrial networks. This innovation drastically reduces the operational cost and complexity of adding satellite connectivity, delivering on the promise of converged IoT connectivity to meet the needs of scaling IoT businesses, regardless of geographical challenges or local network infrastructure limitations.
"Our collaboration with Skylo underscores our commitment to expanding the SuperNetwork to create new opportunities and open new markets for IoT businesses everywhere," said Frank Stoecker, CEO and emnify founder. "The addition of satellite connectivity exemplifies the power of the SuperNetwork to go beyond traditional networks to provide dedicated IoT connectivity with truly global reach.”
Skylo, the leader in satellite connectivity, shares in the excitement. “We are thrilled to partner with emnify to offer friction-free access to NTN, ensuring that businesses are always connected for critical needs,” said Parthsarathi Trivedi, CEO and Skylo co-founder. "This innovation in IoT connectivity provides new levels of reliability and device availability, expanding IoT’s reach to previously inaccessible areas, and bringing new use cases to life."
“It’s critical that IoT customers have reliable, cost-effective, integrated hardware solutions to take advantage of innovations in IoT connectivity,” said Mehul Udani, Vice President Corporate Technology and Innovation for Murata. “Murata’s combined cellular and NTN radio modules provide a breakthrough in offering converged connectivity around the globe.”
Transformative use cases highlight converged IoT connectivity potential
Remote Monitoring Systems
In remote regions lacking traditional infrastructure, the unparalleled reach of the SuperNetwork with Skylo’s NTN satellite connectivity will enable reliable monitoring of water resources. The SuperNetwork ensures that sensors always use the appropriate network in their location.
According to Matt Trumbo, Director of Product Management for In-Situ, “For our markets, NTN effectively means you can use your cellular devices anywhere – no worrying about coverage, no hassles with local providers and network compatibility. It’s the benefits of traditional satellite data providers at an order of magnitude less in cost and in power consumption. NTN will completely alter how we partner with our customers to create decision-quality information.”
Asset Tracking
The SuperNetwork’s advanced reach and reliability with Skylo’s NTN satellite connectivity is necessary to enable breakthrough use cases and opportunities in asset tracking. High value assets are often stationed permanently or temporarily in remote, previously unconnected areas. Powered by a single emnify SIM, IoT tracking devices and sensors provide continuous data to monitor equipment location, movement and critical telemetry needed for services such as predictive maintenance, usage optimization, and security.
“We're excited about the possibility of merging satellite and cellular connectivity for GPS tracking in remote and rural areas. It's a compelling solution that extends our tracking capabilities to places where conventional cell networks can't reach. This innovation not only broadens our service coverage but also ensures connectivity in the most remote locations, enhancing the reliability of our GPS tracking solutions,” said Adam Ben Jacob Director of Sales, Support & Technology for OneStep GPS. “Our team is eager to dive into testing and deployment.”
New SuperNetwork Eval Program
emnify and Skylo are offering a new evaluation program for customers interested in deploying converged cellular and satellite connectivity. This program will allow selected participants to work directly with emnify and Skylo to test their use cases and the capabilities of the SuperNetwork to jumpstart their converged IoT connectivity transformation with hands-on support and guidance from a team of IoT experts.
Deploying IoT Satellite Roundtable at Mobile World Congress, Las Vegas
emnify is hosting an invite-only roundtable discussion on September 26, from 2:30-5:30. The roundtable, moderated by Matt Hatton, founding partner at Transforma Insights, features speakers from Skylo and Murata to discuss this next level of connectivity and how IoT businesses can take advantage of increased availability, lower power consumption, and a limitless footprint.
To register your interest in attending the roundtable please visit https://www.mwclasvegas.com/agenda/session/deploying-iot-satellite-in-2024-discover-new-technologies-to-expand-your-iot-connectivity.
To learn more about converged cellular and satellite IoT connectivity and the SuperNetwork, stop by the emnify booth, #839, at Mobile World Congress.
For more information and updates on the event please visit https://www.emnify.com/events/mwc-las-vegas-2023.
About emnify
emnify is the leading cloud building block for cellular communications in the IoT stack, connecting millions of IoT devices globally – from electric vehicles to energy meters, alarm systems to GPS trackers, thermometers to health wearables. The emnify API and SIM technology connect and secure any kind of IoT deployment to its application back-end. emnify’s cloud-native integrations and no-code workflows ensure seamless lifecycle scalability for deployments of all sizes – from start-up to enterprise. The award-winning emnify IoT SuperNetwork is the largest globally distributed mobile cloud core network of its kind, supporting local network access (2G – 5G, LTE-M, NB-IoT and satellite) in over 180 countries from more than 25 cloud regions – and counting. emnify’s solution is built on partnerships with the leading hyperscale cloud service providers, system integrators, and hundreds of network operators worldwide.
About Skylo
Skylo Technologies is an NTN service provider based in Mountain View, CA, offering a service that allows smartphone and IoT cellular devices to connect directly over existing satellites. Devices connected over satellite are managed and served by Skylo’s commercial NTN vRAN, featuring a 3GPP standards-based cloud-native base station and core. Skylo works with existing satellite operators, terrestrial mobile network operators, and device makers to provide subscribers an anywhere, anytime connectivity solution that seamlessly roams between terrestrial and satellite networks. Skylo’s focus is on enabling connected services for people outdoors and connected workflows for machines at work across critical industries such as agriculture, maritime, logistics, mining, and others, in addition to mass-market consumer devices. For more information, visit www.skylo.tech, contact info@skylo.tech, or follow us on LinkedIn and Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230921763925/en/
Contact information
emnify Media Relations Contact:
Jennifer Baisch
emnify
media@emnify.com
Skylo Media Relations Contact:
Rosa Lear
Skylo Technologies
press@skylo.tech
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
